787 related articles for article (PubMed ID: 19835884)
1. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor structure and its implications for the IGF-1 receptor.
Lawrence MC; McKern NM; Ward CW
Curr Opin Struct Biol; 2007 Dec; 17(6):699-705. PubMed ID: 17851071
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into ligand-induced activation of the insulin receptor.
Ward C; Lawrence M; Streltsov V; Garrett T; McKern N; Lou MZ; Lovrecz G; Adams T
Acta Physiol (Oxf); 2008 Jan; 192(1):3-9. PubMed ID: 18171424
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor.
Garrett TP; McKern NM; Lou M; Frenkel MJ; Bentley JD; Lovrecz GO; Elleman TC; Cosgrove LJ; Ward CW
Nature; 1998 Jul; 394(6691):395-9. PubMed ID: 9690478
[TBL] [Abstract][Full Text] [Related]
5. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
Kolychev AP
Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
[TBL] [Abstract][Full Text] [Related]
6. Structure of the insulin receptor ectodomain reveals a folded-over conformation.
McKern NM; Lawrence MC; Streltsov VA; Lou MZ; Adams TE; Lovrecz GO; Elleman TC; Richards KM; Bentley JD; Pilling PA; Hoyne PA; Cartledge KA; Pham TM; Lewis JL; Sankovich SE; Stoichevska V; Da Silva E; Robinson CP; Frenkel MJ; Sparrow LG; Fernley RT; Epa VC; Ward CW
Nature; 2006 Sep; 443(7108):218-21. PubMed ID: 16957736
[TBL] [Abstract][Full Text] [Related]
7. Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor.
Epa VC; Ward CW
Protein Eng Des Sel; 2006 Aug; 19(8):377-84. PubMed ID: 16772308
[TBL] [Abstract][Full Text] [Related]
8. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors.
Maggi D; Cordera R
Biochem Biophys Res Commun; 2001 Jan; 280(3):836-41. PubMed ID: 11162597
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of signaling pathways for insulin and insulin-like growth factor I.
Lopaczynski W
Acta Biochim Pol; 1999; 46(1):51-60. PubMed ID: 10453981
[TBL] [Abstract][Full Text] [Related]
11. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
Johansson GS; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K
Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560
[TBL] [Abstract][Full Text] [Related]
14. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
[TBL] [Abstract][Full Text] [Related]
15. A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor alpha-chain C-terminal peptide and the site 1 insulin mimetic peptides.
Menting JG; Ward CW; Margetts MB; Lawrence MC
Biochemistry; 2009 Jun; 48(23):5492-500. PubMed ID: 19459609
[TBL] [Abstract][Full Text] [Related]
16. Influence of placental mannose/n-acetyl glucosamine-binding proteins on the interaction of insulin and insulin-like growth factors with their receptors.
Nedic O; Filimonovic D; Mikovic Z; Masnikosa R
Biochemistry (Mosc); 2011 Sep; 76(9):1003-8. PubMed ID: 22082268
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
Forbes BE
Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced conformational change in the minimized insulin receptor.
Schlein M; Havelund S; Kristensen C; Dunn MF; Kaarsholm NC
J Mol Biol; 2000 Oct; 303(2):161-9. PubMed ID: 11023783
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
